ALC - Onconova Therapeutics GAAP EPS of -$0.23 beats by $0.06 revenue of $0.06M misses by $0.01M
2023-11-14 16:48:50 ET
More on Alcon
- Alcon: Buy An Eyecare Leader With $2 Billion In Quarterly Sales
- JP Morgan upgrades Alcon to overweight in wake of earnings beat
- Seeking Alpha’s Quant Rating on Alcon
- Historical earnings data for Alcon
- Dividend scorecard for Alcon
For further details see:
Onconova Therapeutics GAAP EPS of -$0.23 beats by $0.06, revenue of $0.06M misses by $0.01M